82 related articles for article (PubMed ID: 15464392)
1. 227Th-EDTMP: a potential therapeutic agent for bone metastasis.
Washiyama K; Amano R; Sasaki J; Kinuya S; Tonami N; Shiokawa Y; Mitsugashira T
Nucl Med Biol; 2004 Oct; 31(7):901-8. PubMed ID: 15464392
[TBL] [Abstract][Full Text] [Related]
2. 177Lu-EDTMP: a potential therapeutic bone agent.
Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
[TBL] [Abstract][Full Text] [Related]
3. Thorium and actinium polyphosphonate compounds as bone-seeking alpha particle-emitting agents.
Henriksen G; Bruland OS; Larsen RH
Anticancer Res; 2004; 24(1):101-5. PubMed ID: 15015582
[TBL] [Abstract][Full Text] [Related]
4. Preparation of (166)Dy/(166)Ho-EDTMP: a potential in vivo generator system for bone marrow ablation.
Pedraza-López M; Ferro-Flores G; de Murphy CA; Tendilla JI; Villanueva-Sánchez O
Nucl Med Commun; 2004 Jun; 25(6):615-21. PubMed ID: 15167523
[TBL] [Abstract][Full Text] [Related]
5. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Mathew B; Chakraborty S; Das T; Sarma HD; Banerjee S; Samuel G; Venkatesh M; Pillai MR
Appl Radiat Isot; 2004 May; 60(5):635-42. PubMed ID: 15082040
[TBL] [Abstract][Full Text] [Related]
6. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
[TBL] [Abstract][Full Text] [Related]
7. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
[TBL] [Abstract][Full Text] [Related]
8. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
9. Production of 105Rh-EDTMP and its bone accumulation.
Ando A; Ando I; Tonami N; Kinuya S; Okamoto N; Sugimoto M; Fukuda N; Matsumoto S
Appl Radiat Isot; 2000 Feb; 52(2):211-5. PubMed ID: 10697730
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel "foreign carrier theory".
Toegel S; Mien LK; Wadsak W; Eidherr H; Viernstein H; Kluger R; Ettlinger D; Kletter K; Dudczak R; Mitterhauser M
Nucl Med Biol; 2006 Jan; 33(1):95-9. PubMed ID: 16459264
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis.
Vigna L; Matheoud R; Ridone S; Arginelli D; Della Monica P; Rudoni M; Inglese E; Brambilla M
Phys Med; 2011 Jul; 27(3):144-52. PubMed ID: 20864370
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical.
Khalid M; Bokhari TH; Ahmad M; Bhatti HN; Iqbal M; Ghaffar A; Qadir MI
Pak J Pharm Sci; 2014 Jul; 27(4):813-8. PubMed ID: 25015445
[TBL] [Abstract][Full Text] [Related]
13. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic and genotoxic effect of the [166Dy]Dy/166Ho-EDTMP in vivo generator system in mice.
Pedraza-López M; Ferro-Flores G; Arteaga de Murphy C; Morales-Ramírez P; Piedras-Ross J; Murphy-Stack E; Hernández-Oviedo O
Nucl Med Biol; 2004 Nov; 31(8):1079-85. PubMed ID: 15607490
[TBL] [Abstract][Full Text] [Related]
15. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
[TBL] [Abstract][Full Text] [Related]
16. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.
Chakraborty S; Das T; Banerjee S; Balogh L; Chaudhari PR; Sarma HD; Polyák A; Máthé D; Venkatesh M; Janoki G; Pillai MR
Cancer Biother Radiopharm; 2008 Apr; 23(2):202-13. PubMed ID: 18454689
[TBL] [Abstract][Full Text] [Related]
17. Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose.
Deilami-Nezhad L; Moghaddam-Banaem L; Sadeghi M
Appl Radiat Isot; 2017 Nov; 129():108-116. PubMed ID: 28843158
[TBL] [Abstract][Full Text] [Related]
18. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
Sohaib M; Ahmad M; Jehangir M; Perveen A
Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
[TBL] [Abstract][Full Text] [Related]
19. Comparing high LET 227Th- and low LET 177Lu-trastuzumab in mice with HER-2 positive SKBR-3 xenografts.
Abbas N; Heyerdahl H; Bruland ØS; Brevik EM; Dahle J
Curr Radiopharm; 2013 Jun; 6(2):78-86. PubMed ID: 23551110
[TBL] [Abstract][Full Text] [Related]
20. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
El-Mabhouh A; Mercer JR
Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
